tirzepatide glp 1 gip Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction Tirzepatide (4 x 15mg Vial)

The Food and Drug Administration said in a court filing late Friday that it would allow pharmacists to continue making compounded versions of tirzepatide the active ingredient in Eli Lillys diabetes and weight loss drugs Mounjaro and Zepbound while it reconsiders its decision to remove the drug from its nationwide shortage list

Tirzepatide is actually more advanced than GLP-1 medications

Dinner traffic has fallen 6% among consumers who have been taking the medication regularly, according to Baggett

Bring your pharmacy label or a letter from your prescribing provider confirming the medication

JPMorgan estimates the growing use of the medications could wipe out $30 billion to $55 billion in annual sales for the food and beverage industry as soon as 2030

GLP-1, or glucagon-like peptide-1, is a powerful hormone that plays a crucial role in regulating blood sugar, enhancing insulin secretion, and promoting feelings of fullness